Li Xu

ORCID: 0000-0001-7376-4771 · 21 papers in corpus · active 2015-2026

Study types

  • article 10
  • dataset 6
  • other 2
  • review 2
  • preprint 1

Condition tags

  • adenomyosis 13
  • endometriosis 6
  • mesh:D004715 3
  • dysmenorrhea 1
article 2026
·doi:10.3389/fmed.2026.1776698

Objective: To systematically evaluate the efficacy and safety of blood-invigorating and stasis-resolving Chinese herbal medicines (BISMs) when combined with conventional clinical therapy for endometriosis, and to provide evidence-based guid…

other 2026
BMC women's health ·doi:10.1186/s12905-026-04415-0

BACKGROUND: Synchronous multiple primary malignancies (SMPMs) involving the uterus and ovary pose significant diagnostic challenges, particularly in distinguishing independent primary tumors from metastatic disease when tumors exhibit overl…

article 2026
·doi:10.1007/s00281-026-01077-w

Adenomyosis is a common and difficult disease in gynecology. Its main clinical manifestations include uterine hypertrophy, excessive menstruation, pelvic pain and infertility, which have a serious impact on women's health. Seriously affects…

article 2025
Reproductive toxicology (Elmsford, N.Y.) ·doi:10.1016/j.reprotox.2025.109024
other 2025
Hereditas ·doi:10.1186/s41065-025-00590-6

BACKGROUND: Endometriosis (EMs), a common gynecological disorder, involves complex molecular mechanisms. Metabolic reprogramming (MR) has been recognized as a hallmark of EMs, contributing to lesion survival and immune microenvironment remo…

article 2024
Phytomedicine : international journal of phytotherapy and phytopharmacology ·doi:10.1016/j.phymed.2024.155461

BACKGROUND: The active ingredients of the Chinese medical herb Paris polyphylla, P. polyphylla ethanol extract (PPE) and polyphyllin I (PPI), potentially inhibit epithelial-mesenchymal transition (EMT) in tumors. However, the roles of these…

article 2023
Frontiers in microbiology ·doi:10.3389/fmicb.2023.1188458

Background Recent studies have shown that an imbalance in gut microbiota (GM) may not always be associated with endometriosis (EMS). To investigate this further, we conducted a two-sample Mendelian randomization study. Methods MR analysis w…

article 2023
Tissue & cell ·doi:10.1016/j.tice.2023.102284

Because adenomyosis (AM) ectopic primary cells are hard to come by, have a short lifespan, and the characteristics that alter over time, their utility in AM research is constrained. This study aimed to establish a line of immortalized human…

article 2023
Journal of inflammation research ·doi:10.2147/jir.s402734

Purpose: Adenomyosis (AM) is a common benign uterine disorder that has deleterious effects on women's health. However, the pathogenesis of AM is not clearly understood. We aimed to investigate the pathophysiological changes and molecular me…

article 2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/2624434

Objective: Sm. (C-P) drug pair in the treatment of adenomyosis (AM) based on network pharmacology and animal experiments. Methods: Via a network pharmacology strategy, a drug-component-target-disease network (D-C-T-D) and protein-protein in…

dataset 2021
·doi:10.6084/m9.figshare.14183837

Additional file 1: Figure S1. HE staining and QC. (A) Samples from the AM_CTRL, AM_EM and AM_EC groups were HE stained, and the black arrow shows the gland invading the muscular layer. (B) X axis represents the number of UMI in each cell, a…

dataset 2021
·doi:10.6084/m9.figshare.14183840

Additional file 2: Table S1. Doublet score and predicted doublets.

dataset 2021
·doi:10.6084/m9.figshare.14183843

Additional file 3: Table S2. DEGs of AM_EC vs. AM_EM (all cell types).

dataset 2021
·doi:10.6084/m9.figshare.14183846

Additional file 4: Table S3. Coexisting genes in Venn.

dataset 2021
·doi:10.6084/m9.figshare.14183849

Additional file 5: Table S4. DEGs of AM_EC vs. AM_EM (epithelial cells).

dataset 2021
·doi:10.6084/m9.figshare.14183852

Additional file 6: Table S5. Clinical characteristics of AM patients and hysteromyoma samples used in this study.

review 2021
·doi:10.21037/apm-20-825

BACKGROUND: Oligomenorrhea is one of the most frequent gynecologic complaints that interferes with women's life quality. Treatment using traditional Chinese medicine (TCM) is a preferred alternative therapy for oligomenorrhea. However, syst…

article 2021
Cell & bioscience ·doi:10.1186/s13578-021-00562-z

BACKGROUND: Adenomyosis (AM) is a common benign chronic gynaecological disorder; however, the precise pathogenesis of adenomyosis is still poorly understood. Single-cell RNA sequencing (scRNA-seq) can uncover rare subpopulations, explore ge…

review 2021
International journal of medical sciences ·doi:10.7150/ijms.55789

Endometriosis (EMs) is recorded as Zheng Jia in traditional Chinese medicine (TCM) books. Guizhi Fuling Pills (GFPs), a classic prescription for promoting blood circulation and removing blood stasis, is widely used for women's blood stasis …

preprint 2020
·doi:10.21203/rs.3.rs-127243/v1
article 2015

Objective:The present research aimed to explore the involvement of MMP2/9in the pathogenesis of uterine adenomyosis and mechanisms of PVA combined recombinant human endostatin.Methods:80cases of uterine denomyosis patients were divided into…